Results 121 to 130 of about 11,536 (182)

CT-guided ablation for stage I non-small cell lung cancer: a comparative study between cryoablation and microwave ablation. [PDF]

Cancer Imaging
Han R, Wang HT, Hu JL, Teng F, Lin J, Yu ZH, Lu Y.   +6 more
europepmc   +1 more source

AI-assisted cryo-dose estimation and tissue injury modeling for assessing side effects in MRI-guided prostate cryoablation: a retrospective study. [PDF]

Phys Med Biol
Moreira P, Ma M, Fordham N, Vangel M, Tempany C, Tuncali K, Tokuda J.   +6 more
europepmc   +1 more source

Cryoablation in Redo Surgery for a Recurrent Intimal Sarcoma of the Left Atrium. [PDF]

Interdiscip Cardiovasc Thorac Surg
Yasuoka K, Matsuzaki K, Imai A, Sato M, Watanabe Y.   +4 more
europepmc   +1 more source

Cryoablation - waiting for the inevitable.

Endoscopy
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cryoablation:

Journal of Cardiovascular Electrophysiology, 2004
The use of cryoablation in the electrophysiology lab provides some distinct advantages not seen with conventional radiofrequency ablation. Ice mapping allows a functional assessment of a putative ablation site prior to the formation of a permanent lesion.
Allan C, Skanes, George, Klein, Andrew, Krahn, Raymond, Yee   +3 more
openaire   +2 more sources

Cryoablation in the Musculoskeletal System

Current Problems in Diagnostic Radiology, 2008
Pain palliation can be challenging in patients with metastases to the musculoskeletal system, and conventional therapy can be less than optimal for pain management. Recent advances in technology have allowed for the addition of image-guided ablation to the armamentarium for treating musculoskeletal metastases. This article focuses on one such technique,
Steven R, Ullrick, Jeffrey J, Hebert, Kirkland W, Davis   +2 more
openaire   +2 more sources

Cryoablation and immunotherapy of cancer

Current Opinion in Biotechnology, 2020
Cryoablation is a hypothermic modality exercised as a focal therapy for annihilating cancer lesions. Its application leaves the ablated tumor in situ, allowing multifarious tumor antigens to be available to the host's immune system. This ensues the activation of innate and adaptive immunity against the tumor antigens.
Chakradhar Yakkala, Alban Denys, Lana Kandalaft, Rafael Duran   +3 more
openaire   +3 more sources